New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.
Michael David Chuong, MD, discusses how SBRT has become a leading option for treating patients with colorectal liver ...
Johnson & Johnson (NYSE:JNJ) today announced new longer follow-up results from the investigational Phase 1b/2 OrigAMI-1 study evaluating amivantamab-vmjw, a bispecific antibody targeting epidermal ...
For years, researchers have noted an alarming rise in colorectal cancer in younger people that’s not fully explained away by ...
The family thought they had finally cracked the impossible puzzle of modern parenting: a trusted grandma watching the kids so ...